JUL 17, 2026 · REGULATORY LABEL UPDATE
FDA supplemental approval: Pregabalin (Labeling)
U.S. Food and Drug Administration
FDA supplemental approval of labeling for pregabalin extended-release tablets; this is a regulatory action, not a clinical evidence report.
Reported
Approval date2026-07-17
Application typeANDA211687 supplement (labeling)
SponsorALVOGEN